Tildren 5 mg/ml 10 x 10 ml
Le numéro d’autorisation de mise sur le marché de votre pays ne pas répertorié ? Il s'agit alors d'un produit cascade. Cliquez ici pour plus d'informations.
En stock
Indication
To aid in the treatment of lameness associated with osteolytic processes observed in bone spavin and in navicular syndrome of less than 6 months.
Composition
The powder contains: Tiludronic Acid (as disodium Acid) 50 mg.
The solvent vial contains: water for injection 10 ml.
The solution after reconstitution contains: Tiludronic acid 5 mg/ml
Indications d'utilisation
0.1 mg of tiludronic acid per kg of body weight per day for 10 days by slow intravenous route, i.e. 1 ml per 50 kg of body weight per day of a reconstituted solution containing 5 mg/ml of tiludronic acid.
The reconstituted solution is obtained by adding under aseptic conditions the solvent to the powder and gently mixing them.
- The product should be administered over 20 to 30 seconds for 10 ml.
- The side of the site of injection must be alternated from day to day.
- The product should be used immediately and not stored after reconstitution.
- Do not exceed the recommended dosage.